Most importantly, compared with the 5 years AUC values of these established prognostic markers (transcriptomic classification, mutation subtype, tumor stage and BRAF mutant), our signature can achieve higher accuracy value (Figure 8G). This evidence concerns the gene BRAF and neoplasm.